Specialist background
- Key decision-maker for vendor selection and reimbursement
- In-depth knowledge of provider networks, managing various value- and fee-for-service-based relationships
- Actively involved across business initiatives, needs and requirements for value-based care providers
- Well-versed in Evolent Health’s positioning and competitive merits
Questions
1.
Maybe we could start, just by discussing where you think we are on that journey from fee-for-service to value-based care, because there are obviously lots of different statistics floating around as to how much risk sharing has actually really penetrated the market, and how much the old behaviours and silos are still holding it back, not withstanding the need to control cost. That's, I guess, front of everybody's minds these days.
2.
Maybe you can give me a sense of the percentage of penetration of those kind of value-based care arrangements relative to fee-for-service, where you're working, if that's representative at all of what the national picture is these days, and the rate at which, perhaps, it's shifting from fee-for-service towards value-based care.
3.
We can talk a little bit specifically about how Evolent compare with the other models that play within value-based care. I can see their technology is very useful, but if they don't control what the primary care physicians actually do with the technology once they have it, then that could lead to sub-optimal outcomes and that could feed back into a bad outcome for Evolent trying to prove their capabilities. Maybe you can frame that risk for me, how real it is, and then compare and contrast with other providers of more integrated value-based care solutions that operate in the US at the moment.
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary 48 hour week trial
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited
